Theresa Wingrove, SVP OF REGULATORY AFFAIRS at ImmunoGen, Inc. (IMGN), sold 375,334 shares at $29.64 ($11.1M) on 2024-01-16, disclosed to the SEC on 2024-01-18.
Scheduled sale ($11.1M) by SVP OF REGULATORY AFFAIRS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.64 | 187,667 | $5.6M | 50.0% |
| 2 | $29.64 | 187,667 | $5.6M | 50.0% |
| Total | $29.64 avg | 375,334 | $11.1M | 100% |
| Filing → |
| IMGN | SELL | 2023-12-01 | $9.7M | — | Filing → |
| IMGN | SELL | 2023-11-17 | $5.3M | — | Filing → |
| IMGN | SELL | 2023-11-08 | $650K | — | Filing → |